Mazindol Demonstrates Low Risk for Drug Interactions in Narcolepsy Treatment
Swiss clinical-stage biopharmaceutical company NLS Pharmaceutics Ltd announced positive data from five in vitro drug-drug interaction studies investigating mazindol.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
